Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

SFW Capital Partners invests in lab equipment maker Caron Products and Services

By Chris Newmarker | January 21, 2021

Caron Products and ServicesPrivate equity firm SFW Capital Partners recently announced the recapitalization of lab equipment maker Caron Products and Services.

The financial terms of the deal were not disclosed.

Owned by the Christy family and management, Caron (Marietta, Ohio) manufactures a line of environmental testing chambers, incubators and growth chambers. The equipment goes toward FDA-required QA/QC stability testing during drug development and manufacturing, incubation in clean-room environments, and growth of samples in academic research.

“We are delighted to build on our success over the last decade and partner with SFW to continue to serve our customers with innovative laboratory products,” Caron CEO Steve Keiser said in a Jan. 12 news release.

“We are looking forward to leveraging SFW’s expertise and resources to help accelerate our product roadmap, enhance service and support infrastructure, and engage even more deeply with existing and new customers,” Keiser said.


Filed Under: Drug Discovery and Development
Tagged With: Caron Products and Services, SFW Capital Partners
 

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Related Articles Read More >

Sai Life Sciences to double process R&D capacity with new Hyderabad facility
How stereo-correct data can de-risk AI-driven drug discovery
Pfizer stock jumps 14% as TrumpRx drug pricing deal eases tariff fears
See it in 1 second, act in 60: Eschbach’s take on how visual factories enable measurable decisions
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE